Det overlap, der er i de kønsbaserede farmakokinetiske forskelle i clearance- området, retfærdiggør ikke en anbefaling om lavere dosis til kvindelige patienter.
Based upon the overlap in the range of clearance, gender-based pharmacokinetic differences do not justify the recommendation for using a lower dose for female patients.